124 related articles for article (PubMed ID: 35569565)
1. Spontaneous partial recovery of striatal dopaminergic uptake despite nigral cell loss in asymptomatic MPTP-lesioned female minipigs.
Lillethorup TP; Noer O; Alstrup AKO; Real CC; Stokholm K; Thomsen MB; Zaer H; Orlowski D; Mikkelsen TW; Glud AN; Nielsen EHT; Schacht AC; Winterdahl M; Brooks DJ; Sørensen JCH; Landau AM
Neurotoxicology; 2022 Jul; 91():166-176. PubMed ID: 35569565
[TBL] [Abstract][Full Text] [Related]
2. The DaNeX study of embryonic mesencephalic, dopaminergic tissue grafted to a minipig model of Parkinson's disease: preliminary findings of effect of MPTP poisoning on striatal dopaminergic markers.
Danielsen EH; Cumming P; Andersen F; Bender D; Brevig T; Falborg L; Gee A; Gillings NM; Hansen SB; Hermansen F; Johansen J; Johansen TE; Dahl-Jørgensen A; Jørgensen HA; Meyer M; Munk O; Pedersen EB; Poulsen PH; Rodell AB; Sakoh M; Simonsen CZ; Smith DF; Sørensen JC; Ostergård L; Zimmer J; Gjedde A; Møller A
Cell Transplant; 2000; 9(2):247-59. PubMed ID: 10811397
[TBL] [Abstract][Full Text] [Related]
3. Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs.
Lillethorup TP; Glud AN; Alstrup AKO; Mikkelsen TW; Nielsen EH; Zaer H; Doudet DJ; Brooks DJ; Sørensen JCH; Orlowski D; Landau AM
Exp Neurol; 2018 May; 303():142-152. PubMed ID: 29428213
[TBL] [Abstract][Full Text] [Related]
4. Continuous MPTP intoxication in the Göttingen minipig results in chronic parkinsonian deficits.
Nielsen MS; Glud AN; Møller A; Mogensen P; Bender D; Sørensen JC; Doudet D; Bjarkam CR
Acta Neurobiol Exp (Wars); 2016; 76(3):199-211. PubMed ID: 27685773
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
Weng CC; Chen ZA; Chao KT; Ee TW; Lin KJ; Chan MH; Hsiao IT; Yen TC; Kung MP; Hsu CH; Wey SP
PLoS One; 2017; 12(3):e0173503. PubMed ID: 28257461
[TBL] [Abstract][Full Text] [Related]
6. Validation of nigrostriatal positron emission tomography measures: critical limits.
Karimi M; Tian L; Brown CA; Flores HP; Loftin SK; Videen TO; Moerlein SM; Perlmutter JS
Ann Neurol; 2013 Mar; 73(3):390-6. PubMed ID: 23423933
[TBL] [Abstract][Full Text] [Related]
7. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
[TBL] [Abstract][Full Text] [Related]
8. MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons.
Xu Y; Tang J; Liu C; Zhao C; Cao S; Yu H; Chen Z; Xie M
Nucl Med Biol; 2021; 96-97():9-18. PubMed ID: 33647803
[TBL] [Abstract][Full Text] [Related]
9. Novel observations with FDOPA-PET imaging after early nigrostriatal damage.
Yee RE; Irwin I; Milonas C; Stout DB; Huang SC; Shoghi-Jadid K; Satyamurthy N; Delanney LE; Togasaki DM; Farahani KF; Delfani K; Janson AM; Phelps ME; Langston JW; Barrio JR
Mov Disord; 2001 Sep; 16(5):838-48. PubMed ID: 11746613
[TBL] [Abstract][Full Text] [Related]
10. In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment.
Tian L; Karimi M; Brown CA; Loftin SK; Perlmutter JS
Brain Res; 2014 Jul; 1571():49-60. PubMed ID: 24845719
[TBL] [Abstract][Full Text] [Related]
11. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
12. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.
Blesa J; Pifl C; Sánchez-González MA; Juri C; García-Cabezas MA; Adánez R; Iglesias E; Collantes M; Peñuelas I; Sánchez-Hernández JJ; Rodríguez-Oroz MC; Avendaño C; Hornykiewicz O; Cavada C; Obeso JA
Neurobiol Dis; 2012 Oct; 48(1):79-91. PubMed ID: 22677034
[TBL] [Abstract][Full Text] [Related]
13. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
Sconce MD; Churchill MJ; Greene RE; Meshul CK
Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
[TBL] [Abstract][Full Text] [Related]
14. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
15. Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice.
Honer M; Hengerer B; Blagoev M; Hintermann S; Waldmeier P; Schubiger PA; Ametamey SM
Nucl Med Biol; 2006 Jul; 33(5):607-14. PubMed ID: 16843835
[TBL] [Abstract][Full Text] [Related]
16. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
17. Comparative assessment of 6-[
Becker G; Bahri MA; Michel A; Hustadt F; Garraux G; Luxen A; Lemaire C; Plenevaux A
J Neurochem; 2017 May; 141(4):626-635. PubMed ID: 28294334
[TBL] [Abstract][Full Text] [Related]
18. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
[TBL] [Abstract][Full Text] [Related]
19. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study.
Doudet DJ; Rosa-Neto P; Munk OL; Ruth TJ; Jivan S; Cumming P
Neuroimage; 2006 Mar; 30(1):26-35. PubMed ID: 16378735
[TBL] [Abstract][Full Text] [Related]
20. "In vivo" visualization by positron emission tomography of the progressive striatal dopamine receptor damage occurring in MPTP-intoxicated non-human primates.
Hantraye P; Loc'h C; Tacke U; Riche D; Stulzaft O; Doudet D; Guibert B; Naquet R; Mazière B; Mazière M
Life Sci; 1986 Oct; 39(15):1375-82. PubMed ID: 3489875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
